[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351194-105":59,"doc-detail-351194-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","expression-analyses-of-fatty-acid-binding-proteins-fabps-in-breast-cancer-subtypes-implications-for-immune-modulation-and-clinical-outcomes","Expression analyses of fatty acid binding proteins (FABPs) in breast cancer subtypes - implications for immune modulation and clinical outcomes","","Expression analyses were performed to clarify how fatty acid binding proteins (FABPs) vary across breast cancer subtypes and how these patterns relate to immune infiltration and clinical features. Bioinformatic profiling used large TCGA and GSE datasets, with prognostic evaluation by Kaplan-Meier methods and immune associations by TIMER2.0. Experimental validation applied qRT-PCR to breast cancer cell lines and human tissue samples. Distinct subtype-linked FABPs were identified, with FABP expression correlating strongly with CD8+ T-cell infiltration and immune modulation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/expression-analyses-of-fatty-acid-binding-proteins-fabps-in-breast-cancer-subtypes-implications-for-immune-modulation-and-clinical-outcomes/351194/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/expression-analyses-of-fatty-acid-binding-proteins-fabps-in-breast-cancer-subtypes-implications-for-immune-modulation-and-clinical-outcomes/351194.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which FABPs were linked to specific breast cancer subtypes in the study?","Question",{"text":112,"@type":113},"FABP4 associated with the luminal A subtype and ER-positive status; FABP5 and FABP7 with the basal subtype and ER-negative status; FABP6 with the HER2-enriched subtype.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did FABP expression relate to immune cell infiltration?",{"text":117,"@type":113},"FABP expression correlated significantly with immune cell infiltration, particularly CD8+ T cells, and suggested involvement in immune modulation and related biological processes.",{"name":119,"@type":110,"acceptedAnswer":120},"What experimental approach was used to validate the bioinformatic findings?",{"text":121,"@type":113},"Quantitative real-time PCR (qRT-PCR) was performed in breast cancer cell lines (MCF7, MDA-MB-231) and MCF10A, with additional validation in a frozen breast cancer tissue cohort (n=38).","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351194,1790315157,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","Original Article  \nExpression analyses of fatty acid binding proteins (FABPs) in breast cancer subtypes: implications for immune modulation and clinical outcomes  \nEman Taha Osman Ali^, Eun-Ji Min^, Wonkyoung Cho^, Young Mi Park^  \nDepartment of Molecular Medicine, College of Medicine, Ewha Womans University, Seoul, Republic of Korea  \nContributions: (I) Conception and design: YM Park, ETO Ali; (II) Administrative support: YM Park; (III) Provision of study materials or patients: YM Park; (IV) Collection and assembly of data: W Cho, ETO Ali, EJ Min; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.  \nCorrespondence to: Young Mi Park, MD, PhD. Professor, Department of Molecular Medicine, College of Medicine, Ewha Womans University, 25  \nMagokdong-ro 2-gil, Gangseo-gu, Seoul 07804, [Republic of Korea. Email: parkym@ewha.ac.kr](Republic of Korea. Email: parkym@ewha.ac.kr).  \nBackground: Fatty acid binding proteins (FABPs) are key regulators of lipid metabolism and are expressed in the stroma of breast cancer. However, their roles in different breast cancer subtypes remain unclear.  \nThis study explored the expression patterns of FABPs across breast cancer subtypes and examined their associations with immune cell infiltration and clinical features using large datasets, with validation performed  \nthrough testing in breast cancer cell lines and human tissue samples.  \nMethods: A comprehensive bioinformatic analysis was performed using The Cancer Genome Atlas (TCGA) and Genomic Spatial Event database (GSE) datasets to investigate FABPs’ expression patterns and prognostic significance in breast cancer. Prognostic outcomes were evaluated with Kaplan-Meier analysis via PROGgeneV2, and clinicopathological associations, including estrogen receptor (ER)/progesterone receptor (PR) status and tumor grades, were examined using Breast Cancer Gene-Expression Miner v5.1 . Immune cell infiltration correlations were assessed through TIMER2.0 . Experimental validation was performed by quantitative real-time polymerase chain reaction (qRT-PCR) in breast cancer cell lines (MCF7 and MDAMB-231) and the non-malignant breast epithelial cell line MCF10A. Independent validation was further  \nconducted in a cohort of frozen breast cancer tissues (n=38) .  \nResults: FABPs exhibited distinct expression patterns across breast cancer subtypes. FABP4 was associated with the luminal A subtype and ER-positive status, FABP5 and FABP7 with the basal subtype and ERnegative status, and FABP6 with the human epidermal growth factor receptor 2 (HER2)-enriched subtype.  \nFunctional analyses suggested their involvement in immune modulation and other biological processes.  \nFABP expression correlated significantly with immune cell infiltration, particularly CD8+ T cells. Although subtype-related trends were observed in breast cancer tissue validation, no statistically significant differences in FABP4-FABP7 mRNA expression were detected among molecular subtypes, likely reflecting limited sample size. In vitro validation showed that FABP4 and FABP5 were downregulated in MCF7 and MDAMB-231 compared to the non-malignant MCF10A. MDA-MB-231 exhibited FABP5 expressions higher than MCF7, whereas FABP4, FABP6, and FABP7 were upregulated inMCF7 compared to MDA-MB-231 . These findings are aligned with tissue data from TCGA and underscore the subtype-specific expression patterns of  \nFABPs.  \nConclusions: This study identified distinct expression patterns ofFABPs across breast cancer subtypes and highlighted their potential roles in immune modulation. These findings offer new insights into the diverse  \nfunctions ofFABPs in breast cancer and their implications for prognosis.  \n^ ORCID: Eman Taha Osman Ali, 0009-0000-0579-1647; Eun-Ji Min, 0009-0004-4329-9943; Wonkyoung Cho, 0000-0001-5521-4186; Young Mi Park, 0000-0001-6558-7410.  \n© AME Publishing Company. Transl Cancer Res 2026;15(2):92 | [https:/","cbCaidT94F8D7rz3","https://ap.wps.com/l/cbCaidT94F8D7rz3","pdf",7118262,"English","# Introduction\n## Expression and subtype specificity\n# Methods\n## Bioinformatic analysis\n## Prognostic evaluation\n## Immune infiltration assessment\n## Experimental validation\n# Results\n## Subtype-associated FABPs\n## Immune modulation links\n## Cell-line and tissue validation\n# Conclusions","[{\"question\":\"Which FABPs were linked to specific breast cancer subtypes in the study?\",\"answer\":\"FABP4 associated with the luminal A subtype and ER-positive status; FABP5 and FABP7 with the basal subtype and ER-negative status; FABP6 with the HER2-enriched subtype.\"},{\"question\":\"How did FABP expression relate to immune cell infiltration?\",\"answer\":\"FABP expression correlated significantly with immune cell infiltration, particularly CD8+ T cells, and suggested involvement in immune modulation and related biological processes.\"},{\"question\":\"What experimental approach was used to validate the bioinformatic findings?\",\"answer\":\"Quantitative real-time PCR (qRT-PCR) was performed in breast cancer cell lines (MCF7, MDA-MB-231) and MCF10A, with additional validation in a frozen breast cancer tissue cohort (n=38).\"}]","Expression analyses of fatty acid binding proteins (FABPs) in breast cancer subtypes - implications for immune modulation and clinical outcomes | PDF",1790093021,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4fd8a60ddb36900b78d18cbff163f456.webp",983,1287,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/06b1d106c515d52688bb78fb2acb2878.webp",982,1286,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f6b6321d6995abe453fba4bb56dfd88f.webp",981,1284,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4294df692a044b9a6743c5bdaeff18e6.webp",980,1283]